Vimab Group (VIMAB) Q2 2025 earnings summary

Executive summary

• Net sales for Q2 2025 were 78.7 MSEK, down 17.5% year-over-year; EBIT was -0.3 MSEK, an improvement from -2.8 MSEK last year.

• Net result for Q2 was -11.2 MSEK, with EPS at -0.4 SEK; cash flow from operations was -0.06 MSEK.

• For H1 2025, net sales were 133.8 MSEK, down 17.6% year-over-year; EBIT was -25.4 MSEK.

• No significant events occurred during the quarter; post-period, Vimab AB was sold for 140 MSEK, expected to positively impact results by ~120 MSEK in Q3.

• Vimab BESS secured a 98 MSEK EPC order for a battery storage park in Sweden after the quarter.

Financial highlights

• Q2 gross margin was 85.1% (86.4% last year); H1 gross margin was 77.4% (77.7%).

• Operating cash flow for Q2 was -0.06 MSEK (13.4 MSEK last year); H1 was -15.7 MSEK (8.0 MSEK).

• Net financial costs increased due to higher leverage, with Q2 finance net at -10.9 MSEK.

• Soliditet (equity ratio) at period end was -1.8% (19.6%).

• Cash and equivalents at period end were 10.2 MSEK.

Outlook and guidance

• Market for renewable energy and battery storage is growing rapidly, with strong demand expected to continue.

• Metalworking and manufacturing segments benefit from increased defense and infrastructure investments in Sweden and Europe.

• Sale of Vimab AB and new battery storage contracts are expected to improve financials in H2 2025.